Bayesian Capital Management’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $216K | Buy |
+520
| New | +$193K | 0.14% | 193 |
|
|
2025
Q4 | – | Sell |
-13,900
| Closed | -$4.8M | – | 529 |
|
|
2025
Q3 | $4.8M | Buy |
+13,900
| New | +$4.2M | 0.98% | 8 |
|
|
2025
Q2 | – | Sell |
-700
| Closed | -$367K | – | 886 |
|
|
2025
Q1 | $367K | Sell |
700
-5,007
| -88% | -$2.56M | 0.06% | 348 |
|
|
2024
Q4 | $2.89M | Buy |
+5,707
| New | +$3.24M | 0.35% | 78 |
|
|
2024
Q3 | – | Sell |
-12,300
| Closed | -$6.26M | – | 1052 |
|
|
2024
Q2 | $6.26M | Buy |
+12,300
| New | +$6.03M | 0.72% | 18 |
|
|
2024
Q1 | – | Sell |
-3,600
| Closed | -$1.9M | – | 1137 |
|
|
2023
Q4 | $1.9M | Sell |
3,600
-7,100
| -66% | -$3.79M | 0.2% | 136 |
|
|
2023
Q3 | $5.39M | Buy |
10,700
+1,150
| +12% | +$566K | 0.62% | 30 |
|
|
2023
Q2 | $4.59M | Buy |
9,550
+5,450
| +133% | +$2.66M | 0.49% | 33 |
|
|
2023
Q1 | $1.94M | Buy |
+4,100
| New | +$1.98M | 0.24% | 114 |
|
|
2022
Q3 | – | Sell |
-2,600
| Closed | -$1.33M | – | 1029 |
|
|
2022
Q2 | $1.33M | Buy |
+2,600
| New | +$1.31M | 0.25% | 106 |
|
|
2021
Q4 | – | Sell |
-1,654
| Closed | -$646K | – | 522 |
|
|
2021
Q3 | $646K | Buy |
+1,654
| New | +$685K | 0.19% | 146 |
|
|
2020
Q4 | – | Sell |
-9,441
| Closed | -$2.94M | – | 671 |
|
|
2020
Q3 | $2.94M | Buy |
9,441
+8,229
| +679% | +$2.53M | 0.72% | 20 |
|
|
2020
Q2 | $357K | Sell |
1,212
-3,188
| -72% | -$913K | 0.08% | 314 |
|
|
2020
Q1 | $1.1M | Buy |
+4,400
| New | +$1.21M | 0.24% | 107 |
|
|
2019
Q4 | – | Sell |
-43,076
| Closed | -$9.36M | – | 761 |
|
|
2019
Q3 | $9.36M | Buy |
43,076
+36,623
| +568% | +$8.84M | 1.77% | 5 |
|
|
2019
Q2 | $1.57M | Sell |
6,453
-8,876
| -58% | -$2.13M | 0.33% | 86 |
|
|
2019
Q1 | $3.79M | Buy |
15,329
+12,500
| +442% | +$3.19M | 0.73% | 20 |
|
|
2018
Q4 | $705K | Buy |
+2,829
| New | +$747K | 0.14% | 213 |
|
|
2018
Q3 | – | Sell |
-7,705
| Closed | -$1.89M | – | 801 |
|
|
2018
Q2 | $1.89M | Buy |
7,705
+5,905
| +328% | +$1.42M | 0.43% | 54 |
|
|
2018
Q1 | $385K | Sell |
1,800
-10,900
| -86% | -$2.49M | 0.1% | 333 |
|
|
2017
Q4 | $2.8M | Buy |
+12,700
| New | +$2.69M | 0.57% | 23 |
|
|
2017
Q1 | – | Sell |
-13,261
| Closed | -$2.12M | – | 699 |
|
|
2016
Q4 | $2.12M | Buy |
+13,261
| New | +$1.98M | 0.53% | 11 |
|
Other funds holding UNH
Bayesian Capital Management's UNH Position: Q2 2026 in Review
Bayesian Capital Management opened a new position in UnitedHealth (UNH) in Q2 2026: 520 shares worth $216K. The stake represents 0.14% of the portfolio and ranks #193 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in UNH as recently as Q3 2025.
Bayesian Capital Management first reported a position in UNH in Q4 2016 and has held it in 22 quarters since. The position peaked at $9.36M in Q3 2019. 3,386 funds tracked by Wall St. Rank hold UNH as of Q2 2026.
- Bayesian Capital Management held 520 shares of UnitedHealth worth $216K as of Q2 2026.
- UnitedHealth was a new Bayesian Capital Management position in Q2 2026.
- UnitedHealth made up 0.14% of Bayesian Capital Management's portfolio in Q2 2026, its #193 holding.
- Bayesian Capital Management first reported a position in UnitedHealth in Q4 2016 and has held it in 22 quarters since.
- Bayesian Capital Management's UnitedHealth position peaked at $9.36M in Q3 2019.
- 3,386 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.
Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.